Schonfeld Strategic Advisors LLC

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1665241 NEW YORK, NY

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$341,504

-$276,781 QoQ

Shares Held

20,124

-48.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#154

of 279 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. AUPH ranks #95 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INBX	Inhibrx Biosciences, Inc.	697,586	$66,096,273
2	AGIO	Agios Pharmaceuticals, Inc.	520,083	$19,300,280
3	JAZZ	Jazz Pharmaceuticals plc	77,272	$18,620,233
4	VRDN	Viridian Therapeutics, Inc.\DE	793,508	$14,576,741
5	MBX	MBX Biosciences, Inc.	248,670	$13,726,584
6	XENE	Xenon Pharmaceuticals Inc.	227,330	$13,721,638
7	PTCT	Ptc Therapeutics, Inc.	147,425	$12,025,457
8	INSM	INSMED Inc	104,378	$11,128,782

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$341,504	20,124	-48.1%	Shares	Sole	2026-08-14
2025-12-31	$618,285	38,764	-55.4%	Shares	Sole	2026-02-17
2025-09-30	$959,449	86,828	+25.6%	Shares	Sole	2025-11-14
2025-03-31	$555,917	69,144	+25.7%	Shares	Sole	2025-05-15
2024-12-31	$493,900	55,000	-6.0%	Shares	Sole	2025-02-14
2024-09-30	$428,805	58,500	-44.0%	Shares	Sole	2024-11-14
2022-09-30	$785,840	104,500	+126.2%	Shares	Sole	2022-11-14
2022-06-30	$464,310	46,200	-11.0%	Shares	Sole	2022-08-15
2021-09-30	$1,148,547	51,900	+89.4%	Shares	Sole	2021-11-16
2021-06-30	$355,104	27,400	+32.4%	Shares	Sole	2021-11-16
2021-03-31	$268,789	20,700	-77.5%	Shares	Sole	2021-05-17
2020-09-30	$1,356,633	92,100	—	Shares	Sole	2020-11-19
No filing history on record for this holder in this stock.